What is Zevra Therapeutics, Inc.'s PP&E (net)?

Zevra Therapeutics, Inc. (ZVRA) reported PP&E (net) of $430K in Q1 2026.

How has Zevra Therapeutics, Inc.'s PP&E (net) changed year-over-year?

Zevra Therapeutics, Inc.'s PP&E (net) increased by 1.9% year-over-year, from $422K to $430K.

What is the long-term trend for Zevra Therapeutics, Inc.'s PP&E (net)?

Over 5 years (2020 to 2025), Zevra Therapeutics, Inc.'s PP&E (net) has grown at a -14.0% compound annual growth rate (CAGR), from $1.04M to $489K.

What does PP&E (net) mean?

Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.

Zevra Therapeutics, Inc. ZVRA PP&E (Net)

PP&E (Net) at other companies

BioMarin PharmaceuticalsBMRN

$958.07M-7.2%

Ultragenyx PharmaceuticalRARE

$239M-8.4%

XER

Xeris Biopharma Holdings, Inc.XERS

$5.03M-4.3%

Eton Pharmaceuticals, Inc.ETON

$372K+1,591%

Theravance BiopharmaTBPH

$5.54M-21.2%

Relay Therapeutics, Inc.RLAY

$1.22M-76.3%

Segments

By geography

See full

UNITED STATES$2.2M—

Other financials

Income statement

See full

Revenue$36.2M+77.5%

Gross profit$34.3M+80.1%

Operating income$52.1M+1,073%

Net income$37.9M+1,323%

EPS (diluted)$0.60+1,100%

Balance sheet

See full

Cash & equivalents$95.6M+156%

Total debt$1.1M-98.1%

Total equity$205.8M+402%

Total assets$278.6M+61.3%

Cash flow

See full

Operating cash flow$6.1M+175%

CapEx$35.0K-64.6%

Free cash flow$6.1M+173%

Valuation

See full

Market cap$773.23M+56.4%

Enterprise value$678.78M+30.8%

P/E6.2×—

P/S6.3×-5.9×

Profitability

See full

Gross margin86.1%+7.2pp

Operating margin-103.9%-43.0pp

Net margin101.6%+60.1pp

FCF margin-75%-30.5pp

Returns & leverage

See full

Return on equity100.7%+60.3pp

Debt / equity0×-1.5×

Current ratio4.9×+1.9×

Where this comes from

Reported directly by Zevra Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: Zevra Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zevra Therapeutics, Inc.'s pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Zevra Therapeutics, Inc.'s PP&E (net)?: Zevra Therapeutics, Inc. (ZVRA) reported PP&E (net) of $430K in Q1 2026.
How has Zevra Therapeutics, Inc.'s PP&E (net) changed year-over-year?: Zevra Therapeutics, Inc.'s PP&E (net) increased by 1.9% year-over-year, from $422K to $430K.
What is the long-term trend for Zevra Therapeutics, Inc.'s PP&E (net)?: Over 5 years (2020 to 2025), Zevra Therapeutics, Inc.'s PP&E (net) has grown at a -14.0% compound annual growth rate (CAGR), from $1.04M to $489K.
What does PP&E (net) mean?: Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.